Research ArticleArticle
The ASAS Health Index: A New Era for Health Impact Assessment in Spondyloarthritis
Sara Alonso, Isla Morante, Mercedes Alperi and Rubén Queiro
The Journal of Rheumatology August 2021, jrheum.200586; DOI: https://doi.org/10.3899/jrheum.200586
Sara Alonso
S. Alonso, MD, M. Alperi, MD, Rheumatology Division, Hospital Universitario Central de Asturias (HUCA), Oviedo-Asturias; I. Morante, MD, Rheumatology Division, Hospital de Sierrallana, Torrelavega-Cantabria; R. Queiro, MD, PhD, Associate Professor, Rheumatology Division, Hospital Universitario Central de Asturias (HUCA), Oviedo-Asturias, and ISPA Translational Immunology Division, Oviedo, Spain. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. R. Queiro, Oviedo University School of Medicine, Rheumatology Division, Hospital Universitario Central de Asturias, Avenida de Roma s/n, 33011, Oviedo, Spain. Email: rubenque7@yahoo.es. Accepted for publication July 23, 2021.
Isla Morante
S. Alonso, MD, M. Alperi, MD, Rheumatology Division, Hospital Universitario Central de Asturias (HUCA), Oviedo-Asturias; I. Morante, MD, Rheumatology Division, Hospital de Sierrallana, Torrelavega-Cantabria; R. Queiro, MD, PhD, Associate Professor, Rheumatology Division, Hospital Universitario Central de Asturias (HUCA), Oviedo-Asturias, and ISPA Translational Immunology Division, Oviedo, Spain. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. R. Queiro, Oviedo University School of Medicine, Rheumatology Division, Hospital Universitario Central de Asturias, Avenida de Roma s/n, 33011, Oviedo, Spain. Email: rubenque7@yahoo.es. Accepted for publication July 23, 2021.
Mercedes Alperi
S. Alonso, MD, M. Alperi, MD, Rheumatology Division, Hospital Universitario Central de Asturias (HUCA), Oviedo-Asturias; I. Morante, MD, Rheumatology Division, Hospital de Sierrallana, Torrelavega-Cantabria; R. Queiro, MD, PhD, Associate Professor, Rheumatology Division, Hospital Universitario Central de Asturias (HUCA), Oviedo-Asturias, and ISPA Translational Immunology Division, Oviedo, Spain. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. R. Queiro, Oviedo University School of Medicine, Rheumatology Division, Hospital Universitario Central de Asturias, Avenida de Roma s/n, 33011, Oviedo, Spain. Email: rubenque7@yahoo.es. Accepted for publication July 23, 2021.
Rubén Queiro
S. Alonso, MD, M. Alperi, MD, Rheumatology Division, Hospital Universitario Central de Asturias (HUCA), Oviedo-Asturias; I. Morante, MD, Rheumatology Division, Hospital de Sierrallana, Torrelavega-Cantabria; R. Queiro, MD, PhD, Associate Professor, Rheumatology Division, Hospital Universitario Central de Asturias (HUCA), Oviedo-Asturias, and ISPA Translational Immunology Division, Oviedo, Spain. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. R. Queiro, Oviedo University School of Medicine, Rheumatology Division, Hospital Universitario Central de Asturias, Avenida de Roma s/n, 33011, Oviedo, Spain. Email: rubenque7@yahoo.es. Accepted for publication July 23, 2021.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
The ASAS Health Index: A New Era for Health Impact Assessment in Spondyloarthritis
Sara Alonso, Isla Morante, Mercedes Alperi, Rubén Queiro
The Journal of Rheumatology Aug 2021, jrheum.200586; DOI: 10.3899/jrheum.200586